Page last updated: 2024-11-01

nifedipine and Osteoporosis, Postmenopausal

nifedipine has been researched along with Osteoporosis, Postmenopausal in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sashidhara, KV1
Kumar, M1
Khedgikar, V1
Kushwaha, P1
Modukuri, RK1
Kumar, A1
Gautam, J1
Singh, D1
Sridhar, B1
Trivedi, R1

Other Studies

1 other study available for nifedipine and Osteoporosis, Postmenopausal

ArticleYear
Discovery of coumarin-dihydropyridine hybrids as bone anabolic agents.
    Journal of medicinal chemistry, 2013, Jan-10, Volume: 56, Issue:1

    Topics: Administration, Oral; Anabolic Agents; Animals; Biomarkers; Bone and Bones; Bone Density; Bone Resor

2013